← back to search

Vicky Whittemore

National Institute of Neurological Disorders and Stroke · US
Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Epilepsy, Medicine, Translational research, Clinical trial, Disease, and Epileptogenesis.
h-index
citations
1,560
works
12
NIH funding
primary concept
email

Recent publications

Beyond the symptom: the biology of fatigue
SLEEP 2023cited by 42position: middledoi
Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress
Epilepsia 2022cited by 137position: middledoi
Identification of clinically relevant biomarkers of epileptogenesis — a strategic roadmap
Nature Reviews Neurology 2021cited by 103position: middledoi
Antiepileptogenesis and disease modification: Progress, challenges, and the path forward—Report of the Preclinical Working Group of the 2018 NINDS‐sponsored antiepileptogenesis and disease modification workshop
Epilepsia Open 2021cited by 40position: middledoi
Common data elements (CDEs) for preclinical epilepsy research: Introduction to CDEs and description of core CDEs. A TASK3 report of the ILAE/AES joint translational task force
Epilepsia Open 2018cited by 33position: middledoi
Preclinical common data elements (<scp>CDE</scp>s) for epilepsy: A joint <scp>ILAE</scp>/<scp>AES</scp> and <scp>NINDS</scp> translational initiative
Epilepsia Open 2018cited by 20position: middledoi
Common data elements for preclinical epilepsy research: Standards for data collection and reporting. A <scp>TASK</scp>3 report of the <scp>AES</scp>/<scp>ILAE</scp> Translational Task Force of the ILAE
Epilepsia 2017cited by 33position: middledoi
Identification and characterization of outcome measures reported in animal models of epilepsy: Protocol for a systematic review of the literature–A <scp>TASK</scp>2 report of the <scp>AES</scp>/<scp>ILAE</scp> Translational Task Force of the ILAE
Epilepsia 2017cited by 17position: middledoi
<i>SCN8A</i> encephalopathy: Research progress and prospects
Epilepsia 2016cited by 135position: middledoi
Issues related to symptomatic and disease‐modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy
Epilepsia 2013cited by 165position: middledoi
Epilepsy therapy development: Technical and methodologic issues in studies with animal models
Epilepsia 2013cited by 51position: middledoi
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
The Lancet 2012cited by 784position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 6 papers (2013–2021) · 5 papers (2013–2021)Helen E. Scharfman · New York University4 papers (2013–2018) · 3 papers (2017–2018)Karen S. Wilcox · University of Utah3 papers (2016–2021)Amy R. Brooks‐Kayal · University of Colorado Denver3 papers (2013–2021)Jacqueline A. French · Epilepsy Foundation3 papers (2017–2018) · 2 papers (2013–2017)Kevin J. Staley · Harvard University2 papers (2013–2021)Manisha Patel · University of Alabama at Birmingham2 papers (2013–2017) · 2 papers (2021–2022) · 2 papers (2021–2021)Terence J. O’Brien · Monash Health2 papers (2013–2021)Brandy Fureman · Barrow Neurological Institute2 papers (2016–2021)Michele Simonato · University of Ferrara2 papers (2017–2021)Jeffrey A. Loeb · University of Illinois Chicago1 papers (2013–2013)David Neal Franz · University of Cape Town1 papers (2012–2012)Jacy L. Wagnon · The Ohio State University1 papers (2016–2016)Helene Cauwel · Novartis (Switzerland)1 papers (2012–2012) · 1 papers (2017–2017)